Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cognitive Impairment in Multiple Sclerosis. | Bioengineering (Basel) | 2023 | 37508898 | PubTator, text mining | PubMed |
| A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development. | Cells | 2023 | 37508495 | PubTator, text mining | PubMed |
| Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. | J Biol Chem | 2023 | 37507012 | PubTator, text mining | PubMed |
| C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types. | bioRxiv | 2023 | 37503230 | PubTator, text mining | PubMed |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | 37493631 | PubTator, text mining | PubMed |
| Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK). | J Enzyme Inhib Med Chem | 2023 | 37489050 | PubTator, text mining | PubMed |
| The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. | Curr Neurovasc Res | 2023 | 37488757 | PubTator, text mining | PubMed |
| Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. | Innovation (Camb) | 2023 | 37485079 | PubTator, text mining | PubMed |
| PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer. | Adv Sci (Weinh) | 2023 | 37469018 | PubTator, text mining | PubMed |
| Expression of mTOR in normal and pathological conditions. | Mol Cancer | 2023 | 37454139 | PubTator, text mining | PubMed |
| Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX. | Int J Mol Sci | 2023 | 37446271 | PubTator, text mining | PubMed |
| The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review. | Int J Mol Sci | 2023 | 37446128 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| The engagement of autophagy in maniac disease. | CNS Neurosci Ther | 2023 | 37438945 | PubTator, text mining | PubMed |
| mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance. | Oncol Res | 2023 | 37415733 | PubTator, text mining | PubMed |
| Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. | Mol Cancer | 2023 | 37415164 | PubTator, text mining | PubMed |
| The regulatory role of lipophagy in central nervous system diseases. | Cell Death Discov | 2023 | 37414782 | PubTator, text mining | PubMed |
| Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. | Int J Mol Sci | 2023 | 37372966 | PubTator, text mining | PubMed |
| Therapeutic Approaches in Pancreatic Cancer: Recent Updates. | Biomedicines | 2023 | 37371705 | PubTator, text mining | PubMed |
| The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. | Cells | 2023 | 37371141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=9